Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
1.180
0.00 (0.00%)
At close: Dec 3, 2024, 4:00 PM
1.200
+0.020 (1.69%)
After-hours: Dec 3, 2024, 6:48 PM EST
Tevogen Bio Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 17.99 | 5.32 | 8.43 | 1.66 |
| Research & Development | 28.22 | 3.52 | 5.29 | 2.96 |
| Operating Expenses | 46.21 | 8.84 | 13.72 | 4.62 |
| Operating Income | -46.21 | -8.84 | -13.72 | -4.62 |
| Interest Expense | -0.49 | -1.21 | -0.93 | -0.6 |
| Interest & Investment Income | 0 | 0 | 0 | 0 |
| EBT Excluding Unusual Items | -47.58 | -10.05 | -14.66 | -5.22 |
| Other Unusual Items | 47.16 | -50.43 | -7.38 | -10.38 |
| Pretax Income | -7.92 | -60.48 | -22.04 | -15.6 |
| Net Income | -7.92 | -60.48 | -22.04 | -15.6 |
| Net Income to Common | -4.5 | -60.48 | -22.04 | -15.6 |
| Shares Outstanding (Basic) | 126 | 25 | 25 | 25 |
| Shares Outstanding (Diluted) | 126 | 25 | 25 | 25 |
| Shares Change (YoY) | 409.77% | -1.99% | 0.69% | - |
| EPS (Basic) | -0.04 | -2.44 | -0.87 | -0.62 |
| EPS (Diluted) | -0.04 | -2.44 | -0.87 | -0.62 |
| Free Cash Flow | -10.93 | -8.3 | -9.13 | -5.38 |
| Free Cash Flow Per Share | -0.09 | -0.34 | -0.36 | -0.21 |
| EBITDA | -46.04 | -8.68 | -13.63 | -4.61 |
| D&A For EBITDA | 0.17 | 0.16 | 0.09 | 0.01 |
| EBIT | -46.21 | -8.84 | -13.72 | -4.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.